Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | signal transducer and activator of transcription 3 (acute-phase response factor) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0072 | 0.0806 | 1 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.015 | 0.2947 | 0.2367 |
Leishmania major | hypothetical protein, conserved | 0.015 | 0.2947 | 0.2367 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0402 | 0.9849 | 1 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0072 | 0.0806 | 0.0233 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0047 | 0.0106 | 0.5 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0064 | 0.0591 | 0.049 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | expressed protein | 0.0408 | 1 | 1 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.015 | 0.2947 | 0.2367 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0043 | 0 | 0.5 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0158 | 0.3168 | 0.2784 |
Trypanosoma brucei | Emopamil binding protein, putative | 0.015 | 0.2947 | 0.2367 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0402 | 0.9849 | 1 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0047 | 0.0106 | 0.5 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0072 | 0.0806 | 0.0233 |
Onchocerca volvulus | 0.015 | 0.2947 | 0.5 | |
Loa Loa (eye worm) | acetyltransferase | 0.0158 | 0.3168 | 0.2784 |
Brugia malayi | STAT protein, DNA binding domain containing protein | 0.0191 | 0.4051 | 0.3737 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0154 | 0.3046 | 0.2972 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0402 | 0.9849 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0402 | 0.9849 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0206 | 0.4462 | 0.4182 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0402 | 0.9849 | 1 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0047 | 0.0106 | 0.5 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0158 | 0.3168 | 0.6464 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0047 | 0.0106 | 0.5 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0158 | 0.3168 | 0.2739 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0072 | 0.0806 | 0.054 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0072 | 0.0806 | 0.0707 |
Schistosoma mansoni | amine GPCR | 0.021 | 0.4578 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0047 | 0.0106 | 0.5 |
Trypanosoma cruzi | Emopamil binding protein, putative | 0.015 | 0.2947 | 0.2367 |
Leishmania major | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.015 | 0.2947 | 0.2367 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0072 | 0.0806 | 0.0229 |
Loa Loa (eye worm) | STAT protein | 0.0191 | 0.4051 | 0.3737 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0064 | 0.0591 | 0.049 |
Trypanosoma cruzi | 3-Beta-hydroxysteroid-delta(8), delta(7)-isomerase, putative | 0.015 | 0.2947 | 0.2367 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 9.87 uM | Inhibitory concentration against signal transducer and activator of transcription 3 (stat3) using 5-carboxyfluoresceinyl-Ala-Tyr(PO3H2)-Leu-Pro-Gln-Thr-Val-NH2 by FP assay | ChEMBL. | 16220982 |
IC50 (binding) | = 9.87000000000001 uM | Inhibitory concentration against signal transducer and activator of transcription 3 (stat3) using 5-carboxyfluoresceinyl-Ala-Tyr(PO3H2)-Leu-Pro-Gln-Thr-Val-NH2 by FP assay | ChEMBL. | 16220982 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.